Related Experiment Videos
Introduction to colorectal cancer
1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, USA.
Seminars in Oncology Nursing
|June 11, 2002
Summary
Despite early detection efforts, many colorectal carcinoma (CRC) patients are diagnosed late, impacting prognosis. New molecularly targeted therapies are emerging, offering hope for improved CRC management.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Colorectal carcinoma (CRC) remains a significant health concern globally.
- Early detection through screening is crucial but often insufficient.
Observation:
- Many patients are diagnosed with advanced CRC, leading to poor prognoses.
- The treatment landscape for CRC has evolved significantly.
Findings:
- The introduction of irinotecan has altered CRC treatment paradigms.
- Numerous novel agents targeting CRC are currently in clinical evaluation.
- Advances in molecular targeting are driving the development of new CRC therapies.
Implications:
- Understanding novel CRC treatments is vital for healthcare providers.
- Nurses play a critical role in administering emerging CRC therapies.
- Knowledge of molecular targets is essential for effective CRC management.